Anzu Special Acquisition Corp I is a blank check company. The company was incorporated in 2020 and is based in Tampa, Florida.
IPO Year: 2021
Exchange: NASDAQ
Website: anzuspac.com
| Date | Price Target | Rating | Analyst |
|---|
4 - Envoy Medical, Inc. (0001840877) (Issuer)
SC 13G/A - Envoy Medical, Inc. (0001840877) (Subject)
SC 13G/A - Anzu Special Acquisition Corp I (0001840877) (Subject)
SC 13G - Anzu Special Acquisition Corp I (0001840877) (Subject)
SC 13G - Anzu Special Acquisition Corp I (0001840877) (Subject)
4/A - Envoy Medical, Inc. (0001840877) (Issuer)
4 - Envoy Medical, Inc. (0001840877) (Issuer)
4 - Envoy Medical, Inc. (0001840877) (Issuer)
4 - Envoy Medical, Inc. (0001840877) (Issuer)
4 - Envoy Medical, Inc. (0001840877) (Issuer)
4 - Envoy Medical, Inc. (0001840877) (Issuer)
4 - Envoy Medical, Inc. (0001840877) (Issuer)
4 - Envoy Medical, Inc. (0001840877) (Issuer)
4 - Envoy Medical, Inc. (0001840877) (Issuer)
4 - Envoy Medical, Inc. (0001840877) (Issuer)
S-1/A - Envoy Medical, Inc. (0001840877) (Filer)
S-1 - Envoy Medical, Inc. (0001840877) (Filer)
10-Q/A - Envoy Medical, Inc. (0001840877) (Filer)
8-K - Envoy Medical, Inc. (0001840877) (Filer)
10-Q - Envoy Medical, Inc. (0001840877) (Filer)
NT 10-Q - Envoy Medical, Inc. (0001840877) (Filer)
8-K - Envoy Medical, Inc. (0001840877) (Filer)
8-K - Envoy Medical, Inc. (0001840877) (Filer)
8-K - Envoy Medical, Inc. (0001840877) (Filer)
8-K/A - Envoy Medical, Inc. (0001840877) (Filer)
Anzu Special Acquisition Corp I (the "Company") (NASDAQ: "ANZU," "ANZUU" and "ANZUW"), announced today that its stockholders voted to approve the Business Combination Agreement with Envoy Medical Corporation ("Envoy"), and the transactions contemplated thereby (the "Business Combination") at the Company's special meeting of stockholders held on September 27, 2023 (the "Special Meeting"). Pursuant to the Business Combination Agreement, Merger Sub will merge with and into Envoy, with Envoy surviving the merger as a wholly owned subsidiary of the Company (the "Merger"). Following the closing of the Merger (the "Closing"), the Company will be renamed "Envoy Medical, Inc.", which is referred t
Anzu Special Acquisition Corp I (the "Company") (NASDAQ: "ANZU," "ANZUU" and "ANZUWS"), announced today that it convened and then adjourned, without conducting any other business, the Company's special meeting of stockholders (the "Special Meeting") held on February 9, 2023. The Special Meeting has been adjourned until 9:30 a.m., Eastern time, on February 21, 2023 (the "Adjourned Special Meeting"). The Adjourned Special Meeting will be held virtually via live webcast at https://web.lumiagm.com/274911563. The record date remains the close of business, Eastern Time, on January 17, 2023. At the Adjourned Special Meeting, stockholders will be asked to vote on a proposal to amend the Company's